Lionsgate Studios stock
LIONNYSELionsgate Studios Corp., TechnologyISIN CA53626N1024
46Score 46 out of 100, Weak
Price and trend
74 / 100
Price history
+111% in one yearThe chart shows daily closes over 3 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 19% above it.
Since October 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 66).
The price is 14% below its 52-week high. Largest decline in 3 years: 55% (May 2024 to July 2025).
Chart figures for advanced users
- SMA 50$11.79
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$11.81
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)66
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$6.64
- The lowest closing price of the last twelve months.
- Resistance$16.40
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- In fiscal 2026 it reported revenue of $2.63B (down 17.6% year on year) and a loss of $198.3M.
- MEQIRI Score 46 out of 100 (Weak): rank 676 of 854 in Technology, median 61.
- Our model puts fair value at $7.38, with the price 91% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Interest barely coveredOperating profit covers interest only 0.4 times.Stability 15
- Above fair valuePrice 91% above the fair value of $7.38.Valuation 45
- Loss-makingLoss of $118.3M over the last 12 months.Fundamentals 33
Its standout strengths are momentum and technical analysis, while fundamentals and stability hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- price up very strongly over the past year
- high price swings
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $5.27 and expensive above $12.29 (uncertainty high, based on the price swings of the past year).
Calculated with a cost of equity of 12.8%. At 13.8% the fair value would be $6.79, at 11.8% it would be $8.10.
Valuation metrics
From the cash-flow model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Jun 2026, revenue rose 47.7% on the same quarter a year earlier. Up to 2025 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 1.3% a year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 40%, operating 6%, net −8%.
Debt & balance sheet
Fiscal 2026Debt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 4 Feb 2027in 83 days
- Last reported
- 5 Nov 2026EPS reported $0.07 (expected −$0.03)above expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 21.6% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $0.400.0%
- Revenue
- $3.35B0.0%
- Earnings per share
- $0.42−21.6%
- Revenue
- $3.47B+1.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −0.1%The company remains highly confident in its fiscal 2027 outlook and continues to expect significant growth in adjusted OIBDA and free cash flow; no change in figures.
“We remain confident that television will achieve significant year-over-year growth in fiscal 2027 due to both our previously announced outlook to double scripted episodic deliveries and our recently announced Power licensing deal with Netflix.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 6 Aug 2026 (fiscal Q1 2027), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Lionsgate Studios
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
854 rated companies in Technology
- This company
- 46
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in the Technology sector
The next larger and next smaller companies by market value
ETFs that hold Lionsgate Studios
Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.10% | 0.30% | €4.28B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.10% | 0.30% | €2.22B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.07% | 0.30% | €964.08M |
Show 5 more
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.06% | 0.30% | €185.82M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.03% | 0.43% | €2.5B |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.03% | 0.35% | €8.27B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.02% | 0.10% | €395.74M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €178.55M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 28 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.